Beneficial role of rapamycin in experimental autoimmune myositis

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Prevel, Nicolas ^a   Allenbach, Yves ^d   Klatzmann, David ^a,b,c,d   Salomon, Benoit ^a,c   Benveniste, Olivier ^d  

^a SORBONNE UNIVERSITÉ   (France)

^b CNRS   (France)

^c Unit of Dermatology   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; KI 67 ANTIGEN; KRUPPEL LIKE FACTOR 2; L SELECTIN; PLACEBO; RAPAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFICACY; EFFECTOR CELL; EXPERIMENTAL AUTOIMMUNE MYOSITIS; EXPERIMENTAL MUSCULOSKELETAL DISEASE; FEMALE; INFLAMMATORY INFILTRATE; LYMPH NODE; LYMPHOID ORGAN; MOUSE; MUSCLE STRENGTH; MYOSITIS; NONHUMAN; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LYMPHOCYTE COUNT; LYMPHOPENIA; MICE; MUSCLE STRENGTH; MUSCLE, SKELETAL; NERVOUS SYSTEM AUTOIMMUNE DISEASE, EXPERIMENTAL; SIGNAL TRANSDUCTION; SIROLIMUS; T-LYMPHOCYTES, REGULATORY;

EID: 84893155628     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074450     Document Type: Article

References (35)

1. Banker BQ (1975) Dermatomyostis of childhood, ultrastructural alteratious of muscle and intramuscular blood vessels. J Neuropathol Exp Neurol 34: 46-75.
2. Dalakas MC (2007) Autoimmune inflammatory myopathies. Handb Clin Neurol 86: 273-301.
3. Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, et al. (2005) Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore) 84: 231-249. (Pubitemid 41026298)
4. van der Meulen MF, Bronner IM, Hoogendijk JE, Burger H, van Venrooij WJ, et al. (2003) Polymyositis: an overdiagnosed entity. Neurology 61: 316-321. (Pubitemid 36975958)
5. Dalakas MC (2012) Pathogenesis and therapies of immune-mediated myopathies. Autoimmun Rev 11: 203-206.
6. Allenbach Y, Solly S, Gregoire S, Dubourg O, Salomon B, et al. (2009) Role of regulatory T cells in a new mouse model of experimental autoimmune myositis. Am J Pathol 174: 989-998.
7. Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4: 330-336. (Pubitemid 36432314)
8. Gambineri E, Torgerson TR, Ochs HD (2003) Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 15: 430-435. (Pubitemid 36774255)
9. Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061. (Pubitemid 36222930)
10. Darrasse-Jeze G, Klatzmann D, Charlotte F, Salomon BL, Cohen JL (2006) CD4+CD25+ regulatory/suppressor T cells prevent allogeneic fetus rejection in mice. Immunol Lett 102: 106-109. (Pubitemid 41606047)
11. Frey O, Petrow PK, Gajda M, Siegmund K, Huehn J, et al. (2005) The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells. Arthritis Res Ther 7: R291-301.
12. Hsu WT, Suen JL, Chiang BL (2006) The role of CD4CD25 T cells in autoantibody production in murine lupus. Clin Exp Immunol 145: 513-519.
13. Scalapino KJ, Tang Q, Bluestone JA, Bonyhadi ML, Daikh DI (2006) Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J Immunol 177: 1451-1459. (Pubitemid 44092478)
14. Terrada C, Fisson S, De Kozak Y, Kaddouri M, Lehoang P, et al. (2006) Regulatory T cells control uveoretinitis induced by pathogenic Th1 cells reacting to a specific retinal neoantigen. J Immunol 176: 7171-7179. (Pubitemid 43849018)
15. Saunders RN, Metcalfe MS, Nicholson ML (2001) Rapamycin in transplantation: a review of the evidence. Kidney Int 59: 3-16. (Pubitemid 32055209)
16. Donia M, Mangano K, Amoroso A, Mazzarino MC, Imbesi R, et al. (2009) Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells. J Autoimmun 33: 135-140.
17. Esposito M, Ruffini F, Bellone M, Gagliani N, Battaglia M, et al. (2010) Rapamycin inhibits relapsing experimental autoimmune encephalomyelitis by both effector and regulatory T cells modulation. J Neuroimmunol 220: 52-63.
18. Lisi L, Navarra P, Cirocchi R, Sharp A, Stigliano E, et al. (2012) Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis. J Neuroimmunol 243: 43-51.
19. Contet C, Rawlins JN, Deacon RM (2001) A comparison of 129S2/SvHsd and C57BL/6JOlaHsd mice on a test battery assessing sensorimotor, affective and cognitive behaviours: implications for the study of genetically modified mice. Behav Brain Res 124: 33-46. (Pubitemid 32567557)
20. Kojima T, Tanuma N, Aikawa Y, Shin T, Sasaki A, et al. (1997) Myosin-induced autoimmune polymyositis in the rat. J Neurol Sci 151: 141-148. (Pubitemid 27421844)
21. Chi H (2012) Regulation and function of mTOR signalling in T cell fate decisions. Nat Rev Immunol 12: 325-338.
22. Cejka D, Hayer S, Niederreiter B, Sieghart W, Fuereder T, et al. (2010) Mammalian target of rapamycin signaling is crucial for joint destruction in experimental arthritis and is activated in osteoclasts from patients with rheumatoid arthritis. Arthritis Rheum 62: 2294-2302.
23. Battaglia M, Stabilini A, Draghici E, Migliavacca B, Gregori S, et al. (2006) Induction of tolerance in type 1 diabetes via both CD4 +CD25+ T regulatory cells and T regulatory type 1 cells. Diabetes 55: 1571-1580. (Pubitemid 44324109)
24. Thomson AW, Turnquist HR, Raimondi G (2009) Immunoregulatory functions of mTOR inhibition. Nat Rev Immunol 9: 324-337.
25. Viola A, Molon B, Contento RL (2008) Chemokines: coded messages for T-cell missions. Front Biosci 13: 6341-6353.
26. Weinreich MA, Takada K, Skon C, Reiner SL, Jameson SC, et al. (2009) KLF2 transcription-factor deficiency in T cells results in unrestrained cytokine production and upregulation of bystander chemokine receptors. Immunity 31: 122-130.
27. Bromley SK, Thomas SY, Luster AD (2005) Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat Immunol 6: 895-901. (Pubitemid 43090444)
28. Debes GF, Arnold CN, Young AJ, Krautwald S, Lipp M, et al. (2005) Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues. Nat Immunol 6: 889-894. (Pubitemid 43090443)
29. Kurobe H, Liu C, Ueno T, Saito F, Ohigashi I, et al. (2006) CCR7-dependent cortex-to-medulla migration of positively selected thymocytes is essential for establishing central tolerance. Immunity 24: 165-177. (Pubitemid 43214586)
30. Sebzda E, Zou Z, Lee JS, Wang T, Kahn ML (2008) Transcription factor KLF2 regulates the migration of naive T cells by restricting chemokine receptor expression patterns. Nat Immunol 9: 292-300. (Pubitemid 351267326)
31. Sinclair LV, Finlay D, Feijoo C, Cornish GH, Gray A, et al. (2008) Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nat Immunol 9: 513-521. (Pubitemid 351560520)
32. Roncarolo MG, Gregori S, Lucarelli B, Ciceri F, Bacchetta R (2011) Clinical tolerance in allogeneic hematopoietic stem cell transplantation. Immunol Rev 241: 145-163.
33. Kaposztas Z, Etheridge WB, Kahan BD (2008) Case report: successful treatment of posttransplant lymphoproliferative disorder and quiescence of dermatomyositis with rituximab and sirolimus. Transplant Proc 40: 1744-1746. (Pubitemid 351853149)
34. Nadiminti U, Arbiser JL (2005) Rapamycin (sirolimus) as a steroid-sparing agent in dermatomyositis. J Am Acad Dermatol 52: 17-19.
35. Banica L, Besliu A, Pistol G, Stavaru C, Ionescu R, et al. (2009) Quantification and molecular characterization of regulatory T cells in connective tissue diseases. Autoimmunity 42: 41-49.